Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis

Journal of Crohn's and Colitis

Volumn 6, Issue 3, 2012, Pages 267-275

  Lee, Thomas W ^a   Kolber, Michael R ^a   Fedorak, Richard N ^a   Van Zanten, Sander Veldhuyzen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anemia; Crohn's disease; Inflammatory bowel disease; Iron deficiency; Iron sucrose; Iron sulfate; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CORTICOSTEROID; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS FUMARATE; HEMOGLOBIN; IRON; MESALAZINE;

ABDOMINAL PAIN; ASTHMA; DIARRHEA; DISEASE ACTIVITY; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG WITHDRAWAL; EDEMA; ENTERITIS; ERYTHEMA; FERRITIN BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; HUMAN; IRON DEFICIENCY ANEMIA; IRON THERAPY; META ANALYSIS; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMALL INTESTINE HEMORRHAGE; STOMACH PAIN; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOPHLEBITIS; ULCERATIVE COLITIS; VOMITING;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; FERRITINS; HEMOGLOBINS; HUMANS; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; IRON; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 84858075234     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2011.09.010     Document Type: Review

References (46)

1. Gasche C., Reinisch W., Lochs H., Parsaei B., Bakos S., Wyatt J., et al. Anemia in Crohn's disease. Importance of inadequate erythropoietin production and iron deficiency. Dig Dis Sci 1994, 39(9):1930-1934.
2. Gisbert J.P., Gomollon F., Gisbert J.P., Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008, 103(5):1299-1307.
3. Bager P., Befrits R., Wikman O., Lindgren S., Moum B., Hjortswang H., et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol 2010 Nov 15.
4. Kulnigg S., Gasche C. Systematic review: managing anaemia in Crohn's disease. Aliment Pharmacol Ther 2006, 24(11-12):1507-1523.
5. Wells C.W., Lewis S., Barton J.R., Corbett S. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis 2006, 12(2):123-130.
6. Patterson A.J., Brown W.J., Powers J.R., Roberts D.C. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health. Qual Life Res 2000, 9(5):491-497.
7. Semrin G., Fishman D.S., Bousvaros A., Zholudev A., Saunders A.C., Correia C.E., et al. Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation. Inflamm Bowel Dis 2006, 12(12):1101-1106.
8. Werner T., Wagner S.J., Martinez I., Walter J., Chang J.S., Clavel T., et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut Nov. 26 2010.
9. Uritski R., Barshack I., Bilkis I., Ghebremeskel K., Reifen R. Dietary iron affects inflammatory status in a rat model of colitis. J Nutr 2004 Sept, 134(9):2251-2255.
10. Carrier J., Aghdassi E., Platt I., Cullen J., Allard J.P. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 2001 DEC, 15(12):1989-1999.
11. Tompkins G.R., O'Dell N.L., Bryson I.T., Pennington C.B. The effects of dietary ferric iron and iron deprivation on the bacterial composition of the mouse intestine. Curr Microbiol 2001 Jul, 43(1):38-42.
12. Seril D.N., Liao J., Ho K.L., Warsi A., Yang C.S., Yang G.Y., et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 2002, 47(6):1266-1278.
13. Blakeborough M.H., Owen R.W., Bilton R.F. Free radical generating mechanisms in the colon: their role in the induction and promotion of colorectal cancer?. Free Radic Res Commun 1989, 6(6):359-367.
14. Babbs C.F. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990, 8(2):191-200.
15. Erichsen K., Hausken T., Ulvik R.J., Svardal A., Berstad A., Berge R.K. Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scand J Gastroenterol 2003, 38(5):543-548.
16. Rasul I., Kandel G.P. An approach to iron-deficiency anemia. Can J Gastroenterol 2001 Nov, 15(11):739-747.
17. de Silva A.D., Tsironi E., Feakins R.M., Rampton D.S. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005, 22(11-12):1097-1105.
18. Gasche C., Berstad A., Befrits R., Beglinger C., Dignass A., Erichsen K., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007 Dec, 13(12):1545-1553.
19. Gasche C., Lomer M.C., Cavill I., Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 2004 Aug, 53(8):1190-1197.
20. Stein J., Hartmann F., Dignass A.U. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol 2010 Nov, 7(11):599-610.
21. Wilson A., Reyes E., Ofman J., Wilson A., Reyes E., Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 2004, 116(Suppl 7A):44S-49S.
22. Stein J., Bager P., Befrits R., Danese S., Gasche C., Margo F., et al. Current European practice in diagnosis and treatment of IBD-associated anaemia. J Crohns Colitis 2011, 5(1):S45-S46.
23. Gisbert J.P., Bermejo F., Pajares R., Perez-Calle J.L., Rodriguez M., Algaba A., et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis 2009, 15(10):1485-1491.
24. Schreiber S., Howaldt S., Schnoor M., Nikolaus S., Bauditz J., Gasche C., et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med 1996, 334(10):619-623.
25. Kulnigg S., Teischinger L., Dejaco C., Waldhor T., Gasche C., Kulnigg S., et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol 2009, 104(6):1460-1467.
26. Unger E.F., Thompson A.M., Blank M.J., Temple R. Erythropoiesis-stimulating agents-time for a reevaluation. N Engl J Med 2010 Jan 21, 362(3):189-192.
27. WHO U, UNU Iron deficiency anemia: assessment, prevention and control. Report of a joint WHO/UNICEF/UNU consultation 1998, World Health Organization, Geneva.
28. Guyatt G.H., Oxman A.D., Ali M., Willan A., McIlroy W., Patterson C. Laboratory diagnosis of iron-deficiency anemia: an overview. J Gen Intern Med 1992 Mar-Apr, 7(2):145-153.
29. Bermejo F., Garcia-Lopez S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009, 15(37):4638-4643.
30. Wish J.B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006, 1(Suppl 1):S4-S8.
31. Louis T.A., Lavori P.W., Bailar J.C., Polansky M. Crossover and self-controlled designs in clinical research. N Engl J Med 1984, 310(1):24-31.
32. Pearson E.S. The percentage limits for the distribution of range in samples from a normal population. Biometrika 1932, 24:404-417.
33. Wiebe N., Vandermeer B., Platt R.W., Klassen T.P., Moher D., Barrowman N.J. A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 2006, 59(4):342-353.
34. Higgins J.P.T., Altman D.G. Chapter 8: assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions 2008, 187-243. John Wiley & Sons, Chichester (UK). Version 5.0.1 ed. J.P.T. Higgins, D.G. Altman (Eds.).
35. Schroder O., Mickisch O., Seidler U., de Weerth A., Dignass A.U., Herfarth H., et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease-a randomized, controlled, open-label, multicenter study. Am J Gastroenterol 2005, 100(11):2503-2509.
36. Lindgren S., Wikman O., Befrits R., Blom H., Eriksson A., Granno C., et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: a randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009, 1-8.
37. Kulnigg S., Stoinov S., Simanenkov V., Dudar L.V., Karnafel W., Garcia L.C., et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008, 103(5):1182-1192.
38. Gutzwiller F.S., Blank P.R., Gasche C., Evstatiev R., Schwenkglenks M., Szucs T.D. Cost effectiveness of standardised ferric carboxymaltose treatment versus individually calculated iron sucrose treatment for IBD-asscoiated iron deficiency anaemia. J Crohns Colitis 2011, 5(1):S70-S71.
39. Ganz T., Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102(3):783-788.
40. Walker A.P., Partridge J., Srai S.K., Dooley J.S. Hepcidin: what every gastroenterologist should know. Gut 2004, 53(5):624-627.
41. Fleming R.E., Bacon B.R. Orchestration of iron homeostasis. N Engl J Med 2005, 352(17):1741-1744.
42. de Silva A.D., Mylonaki M., Rampton D.S., de Silva A.D., Mylonaki M., Rampton D.S. Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy. Inflamm Bowel Dis 2003, 9(5):316-320.
43. Rosado B., Nehra V., Sandborn W. Retrospective review of the role of intravenous iron replacement therapy in treatment of anemia in patients with inflammatory bowel disease. Gastroenterology 2003 APR, 124(4):A524-A524.
44. Bodemar G., Kechagias S., Almer S., Danielson B.G. Treatment of anaemia in inflammatory bowel disease with iron sucrose. Scand J Gastroenterol 2004 MAY, 39(5):454-458.
45. Erichsen K., Ulvik R.J., Grimstad T., Berstad A., Berge R.K., Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005 Nov 1, 22(9):831-838.
46. Katsanos K., Cavalier E., Ferrante M., Van Hauwaert V., Henckaerts L., Schnitzler F., et al. Intravenous iron therapy restores functional iron deficiency induced by infliximab. J Crohns Colitis 2007 Dec, 1(2):97-105.